Publications by authors named "John Mabus"

Claim this Profile
F
FcRn binding is not sufficient for achieving systemic therapeutic levels of immunoglobulin G after oral delivery of enteric-coated capsules in cynomolgus macaques.
Salman Muzammil, John R Mabus, Philip R Cooper, Randall J Brezski, Courtney B Bement

Pharmacol Res Perspect· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups.
Philip R Cooper, Connie M Kliwinski, Robert A Perkinson, Edwin Ragwan, John R Mabus

Front Pharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGF potentiation of VEGF production is cell density dependent in H292 EGFR wild type NSCLC cell line.
Daniel J Ranayhossaini, Jin Lu, John Mabus, Alexis Gervais, Russell B Lingham

Int J Mol Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human and non-human primate intestinal FcRn expression and immunoglobulin G transcytosis.
Pamela J Hornby, Philip R Cooper, Connie Kliwinski, Edwin Ragwan, John R Mabus

Pharm Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative functional in vitro models of human intestinal epithelia.
Amanda L Kauffman, Alexandra V Gyurdieva, John R Mabus, Chrissa Ferguson, Zhengyin Yan

Front Pharmacol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors.
Ellen E Codd, John R Mabus, Brian S Murray, Sui-Po Zhang, Christopher M Flores

Assay Drug Dev Technol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadine.
Ellen E Codd, Judith Baker, Michael R Brandt, Stewart Bryant, Chaozhong Cai, John R Mabus

Toxicol Sci· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.
Janet L Ralbovsky, Joseph G Lisko, Jeffrey M Palmer, John Mabus, Kristen M Chevalier

Bioorg Med Chem Lett· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis